MicroRNAs in prostate cancer: Functional role as biomarkers
MicroRNAs (miRNAs) are small endogenous non-coding molecules that alters gene
expression through post-transcriptional regulation of messenger RNA. Compelling evidence …
expression through post-transcriptional regulation of messenger RNA. Compelling evidence …
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
K Warton, KL Mahon, G Samimi - Endocrine-related cancer, 2016 - erc.bioscientifica.com
The aim of the present study was to perform a systematic review of published studies to
provide a robust estimation of the use of procalcitonin (ProCT) as a diagnostic marker of …
provide a robust estimation of the use of procalcitonin (ProCT) as a diagnostic marker of …
[HTML][HTML] Roles of the canonical myomiRs miR-1,-133 and-206 in cell development and disease
KR Mitchelson, WY Qin - World journal of biological chemistry, 2015 - ncbi.nlm.nih.gov
MicroRNAs are small non-coding RNAs that participate in different biological processes,
providing subtle combinational regulation of cellular pathways, often by regulating …
providing subtle combinational regulation of cellular pathways, often by regulating …
Emerging connections between RNA and autophagy
LB Frankel, M Lubas, AH Lund - Autophagy, 2017 - Taylor & Francis
Macroautophagy/autophagy is a key catabolic process, essential for maintaining cellular
homeostasis and survival through the removal and recycling of unwanted cellular material …
homeostasis and survival through the removal and recycling of unwanted cellular material …
MicroRNAs as diagnostic, prognostic, and therapeutic biomarkers in prostate cancer
AM Aghdam, A Amiri, R Salarinia… - Critical Reviews™ in …, 2019 - dl.begellhouse.com
Prostate cancer is the most prevalent nonskin cancer and a major cause of cancer-related
deaths worldwide. Prostate-specific antigen (PSA) testing is routinely used for screening and …
deaths worldwide. Prostate-specific antigen (PSA) testing is routinely used for screening and …
The potential of microRNAs as human prostate cancer biomarkers: a meta‐analysis of related studies
CJ Song, H Chen, LZ Chen, GM Ru… - Journal of cellular …, 2018 - Wiley Online Library
Prostate cancer (PC) is a very important kind of male malignancies. When PC evolves into a
stage of hormone resistance or metastasis, the fatality rate is very high. Currently …
stage of hormone resistance or metastasis, the fatality rate is very high. Currently …
miRNAs associated with prostate cancer risk and progression
Prostate cancer is the most common malignancy among men in the US. Though
considerable improvement in the diagnosis of prostate cancer has been achieved in the past …
considerable improvement in the diagnosis of prostate cancer has been achieved in the past …
Prostate cancer and microRNAs: New insights into apoptosis
Prostate cancer (PCa) is known as one of the most prevalent malignancies globally and is
not yet curable owing to its progressive nature. It has been well documented that Genetic …
not yet curable owing to its progressive nature. It has been well documented that Genetic …
Overexpression of AR‐regulated lncRNA TMPO‐AS1 correlates with tumor progression and poor prognosis in prostate cancer
W Huang, X Su, W Yan, Z Kong, D Wang… - The …, 2018 - Wiley Online Library
Background Prostate cancer (PCa) is a leading cause of death in males all over the world;
besides, the diagnosis and therapy of it are still challenging. Researchers have revealed …
besides, the diagnosis and therapy of it are still challenging. Researchers have revealed …
[HTML][HTML] Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer
Prostate cancer (PCa) is a leading cause of mortality among males. Long non-coding RNAs
(lncRNAs) are subclass of noncoding RNAs that may act as biomarkers and therapeutic …
(lncRNAs) are subclass of noncoding RNAs that may act as biomarkers and therapeutic …